Melagatran/ximelagatran: market withdrawal.
D000925:Anticoagulants / Q000633:toxicity; D001384:Azetidines / Q000633:toxicity*; D001596:Benzylamines / Q000633:toxicity*; D056486:Chemical and Drug Induced Liver Injury; D017277:Drug Approval; D004335:Drug and Narcotic Control; D005060:Europe; D019981:Health Care Sector; D006801:Humans
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines